Historical Neurolutions Inc., originating in Eric Leuthardt’s Washington University laboratory, developer of IpsiHand EEG-controlled stroke rehabilitation. Merged with Kandu Health in 2025 to form Kandu Inc.; now an endorsed business brand. Successor financing is not Neurolutions financing.
Founded 2007
team@apexlogos.ai · 2 days ago
RELATED team@apexlogos.ai · 2 days ago
BCI research snapshot, reviewed 2026-10-06. Company identity: Neurolutions. This is the pre-import evidence dossier; historical statements about database absence or review are archival. Unverified claims remain research leads, not validated facts.
Part 1/1
# Neurolutions / Kandu
Research accessed: **2026-10-06**. Review draft; no database changes. Original source: user-pasted BCI.INTEL Company Tracker (47 entries).
## Identity and scope
Verified **Neurolutions, Inc.**, founded **2007**, originating in Eric Leuthardt’s Washington University laboratory, St. Louis. It **merged with Kandu Health, Inc. to form Kandu, Inc.**; [official announcement dated 2025-04-08](https://www.neurolutions.com/news/kandu-health-and-neurolutions-merge/ ) datelined **Van Nuys, California**. Current commercial site [neurolutions.com](https://www.neurolutions.com/ ) is an endorsed brand of the combined company; successor [kandu.com](https://kandu.com/ ). Product **IpsiHand** is a non-invasive EEG-controlled stroke upper-limb rehabilitation system. [Official company history](https://www.neurolutions.com/company/ ).
## Audit of pasted claims
| Pasted claim | Finding |
|---|---|
| St. Louis HQ | Historical origin, not sufficient current address. 2025 merger announcement is Van Nuys. |
| Wade Luce CEO | **Unsupported current CEO**. Official merger and current successor leadership name **Leo Petrossian**. |
| Funding — | Incomplete: successor disclosed first close of a $30m financing with merger. |
| IpsiHand | Verified commercial, FDA-cleared device; avoid changing cleared to a blanket FDA-approved claim. |
| Acquired | **More precisely merged**, forming Kandu Inc. Do not use a fabricated acquisition buyer or price. |
[Official merger](https://www.neurolutions.com/news/kandu-health-and-neurolutions-merge/ ), [current successor team](https://kandu.com/ ).
## Investments and ownership
| Date | Entity | Amount/currency/type | Investors / qualification |
|---|---|---|---|
| Initial period 2007–2017, precise dates undisclosed | Neurolutions | Undisclosed early support | **Ascension Health Ventures** per [company history](https://www.neurolutions.com/company/ ). |
| Announced 2025-04-08 | **Kandu Inc., successor** | First close of **USD 30m financing** | Co-led **Ally Bridge Group** and **AMED Ventures**; unnamed existing investors participated. [Official release](https://www.neurolutions.com/news/kandu-health-and-neurolutions-merge/ ). This wording does not prove the full $30m was received at first close. |
**Merger separate from funding:** Kandu Health + Neurolutions combined; no disclosed cash acquisition consideration. Do not attribute all successor financing to standalone Neurolutions. Secondary databases disagree on older totals/rounds; no complete primary round ledger established. The first-close financing is sufficient to reject a known-zero funding interpretation.
## Founders and public team
| Person | Role and time basis | Profile / evidence | Direct profile-picture URL |
|---|---|---|---|
| Leo Petrossian | Current Kandu CEO / director | [Kandu official leadership](https://kandu.com/ ) | https://kandu.com/wp-content/uploads/2025/02/Team-LEO-PETROSSIAN.jpg |
| Nabeel Ahmed | Current Kandu CFO | [Kandu official leadership](https://kandu.com/ ) | https://kandu.com/wp-content/uploads/2025/10/Nabeel-Ahmed.jpg |
| Kirsten Carroll | Current Kandu General Manager and CMO; former Kandu Health founder/CEO | [Kandu official leadership](https://kandu.com/ ) | https://kandu.com/wp-content/uploads/2025/10/Kirsten-Carroll.jpg |
| Andy Schultz | Current Kandu Chief Commercial Officer | [Kandu official leadership](https://kandu.com/ ) | https://kandu.com/wp-content/uploads/2025/10/Andy-Schultz.jpg |
| Javad Seyedzadeh | Current Kandu COO | [Kandu official leadership](https://kandu.com/ ) | https://kandu.com/wp-content/uploads/2025/10/Javad-Seyedzadeh.jpg |
| Seth Wilk | Current Kandu Chief Innovation Officer | [Kandu official leadership](https://kandu.com/ ) | https://kandu.com/wp-content/uploads/2025/02/Seth-Wilk-Headshot-300x300.jpg |
| Eric Leuthardt | Neurolutions founder; historical scientific leadership | [Company origin](https://www.neurolutions.com/company/ ); [WashU profile](https://neurosurgery.wustl.edu/people/eric-c-leuthardt-md/ ) | https://neurosurgery.wustl.edu/app/uploads/2021/12/DSCF2623-Edit-280x386.jpg |
| Daniel Moran | Neurolutions cofounder; historical | [Medical society account](https://slmms.org/wp-content/uploads/2021/06/SLMM_June_2021.pdf ); [WashU faculty portrait](https://engineering.washu.edu/faculty/Daniel-Moran.html ) | https://ik.imagekit.io/mckelvey/faculty/Moran_Dan.jpg?tr=w-322,h-280,fo-face,z-0.5,q-50,dpr-2 |
## Company profile image
Neurolutions profile/logo URL: https://www.neurolutions.com/wp-content/uploads/2025/04/Neurolutions-Endorsed-Logo-RGB-Color-3-13-25.png
Source: [official company HTML](https://www.neurolutions.com/company/ ). Successor logo URL: https://kandu.com/wp-content/uploads/2025/02/Kandu-Logo.svg , [Kandu HTML](https://kandu.com/ ). Current leadership pictures were extracted from Kandu team-card actual image sources. Founder portraits were recovered from named WashU academic profile image sources; both validated HTTP200 image/jpeg.
## Adex match and review decision
No matching Org name found (read-only `%neurolution%` query). Proposed ID **Neurolutions** with merger relationship to **Kandu**. Review whether to create both historical company and active successor; preserve St. Louis as origin only. Do not import Wade Luce as current CEO. Current executive table belongs to Kandu, clearly distinguished from founding Neurolutions team.
Media validation 2026-10-06: named WashU founder portraits returned HTTP200 image/jpeg. Seth full-size asset returned406; the actual page’s 300×300 image variant above returned200 image/jpeg and is preferred. SHOW MORE
Daniel MoranCo-founder
Eric LeuthardtFounder